The electrophilic addition of Br to −endo-benzocyclobutanorbornene× 5 at À 508 led in high yield to the formation of the rearranged dibromides 6 and 7. However, high-temperature bromination of 5 in decalin at 1508 gave exclusively nonrearranged product 8 in 98% yield. From the elimination of nonrearranged product 8, −endo-bromobenzocyclobutanorbornene× 9 and −endo-benzocyclobutanorbornene× 5 were obtained. Similarly, bromination of monobromide 9 at 778 yielded the nonrearranged tribromide 12 in quantitative yield. The dehydrobromination of 12 provided the −endo 11,12-dibromobenzocyclobutanorbornene× 3 in high yield, which is a synthon for the trimerization reactions.
We have performed an investigation on the cyclotrimerisation of molecules having exo-and endo-benzotricyclo[4.2.1.0 2,5 ]nonene skeletons (3 and 4) with the aim of producing their respective cyclotrimers 2 that feature unusual geometries and electronic properties. Activation towards the cyclotrimerisation reaction was performed using the vic-bromostannyl vinyl derivatives and was accomplished under copper-mediated or palladium-catalysed reaction conditions.
The electrophilic addition of bromine to 13-anti-bromo-endo-benzocyclobutenonorbornene 7 at −50 ± 5 °C has led in high yield to the formation of the rearranged dibromides 9, 10 and 11. In addition to this, bromination of exo isomer 8 results in formation of rearranged 9 and non rearranged product 10. However, high-temperature bromination of endo 7 and exo isomer 8 at 77 °C gave only non-rearranged products. The possible role of a substituent in rearrangements is discussed in these systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.